Literature DB >> 20854307

Treatment of chronic pain by long-acting opioids and the effects on sleep.

Kyriaki Mystakidou1, A John Clark, Jürgen Fischer, Annette Lam, Karin Pappert, Ute Richarz.   

Abstract

Chronic pain affects a substantial part of the population, and conveys a huge economic cost to society. Owing to its prevalence and adverse impact, it is of particular interest to clinicians, patients, and the pharmaceutical industry. Conversely, the effects of pain on sleep, sleep on pain, and opioid analgesics on sleep represent a large gap in our understanding, even though pain and sleep are closely linked, inter-related conditions. Chronic pain is often treated by opioid analgesics, which are often thought to promote restful sleep. Indeed it may be assumed that by relieving pain, sleep quality will improve concomitantly. In fact, the reality is much more complicated. The effects of opioids vary according to their formulation and duration of action, and have diverse effects on sleep processes. Despite the prevalence of this problem, there is a surprising paucity of data on the effects of opioids on sleep. This review attempts to summarize the links between pain and sleep, and to look at the studies with opioid analgesics, particularly those with extended-release formulations, that have investigated the effects of opioid analgesics on sleep.
© 2010 Johnson & Johnson Pharmaceutical Services; Pain Practice © 2010 World Institute of Pain.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20854307     DOI: 10.1111/j.1533-2500.2010.00417.x

Source DB:  PubMed          Journal:  Pain Pract        ISSN: 1530-7085            Impact factor:   3.183


  9 in total

1.  Neuropharmacology of Sleep and Wakefulness: 2012 Update.

Authors:  Christopher J Watson; Helen A Baghdoyan; Ralph Lydic
Journal:  Sleep Med Clin       Date:  2012-09-04

2.  Pain and motives for use among non-treatment seeking individuals with prescription opioid dependence.

Authors:  Kelly S Barth; Megan Moran-Santa Maria; Katie Lawson; Stephanie Shaftman; Kathleen T Brady; Sudie E Back
Journal:  Am J Addict       Date:  2013-05-15

3.  The bidirectional relationship between sleep complaints and pain: Analysis of data from a randomized trial.

Authors:  Erin Koffel; Kurt Kroenke; Matthew J Bair; David Leverty; Melissa A Polusny; Erin E Krebs
Journal:  Health Psychol       Date:  2015-06-15       Impact factor: 4.267

4.  Controlled-release oxycodone and naloxone in the treatment of chronic low back pain: a placebo-controlled, randomized study.

Authors:  C Cloutier; John Taliano; W O'Mahony; M Csanadi; G Cohen; I Sutton; D Sinclair; M Awde; S Henein; L Robinson; J Eisenhoffer; P S Piraino; Z Harsanyi; K J Michalko
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

5.  Pain intensity as a moderator of the association between opioid use and insomnia symptoms among adults with chronic pain.

Authors:  Mary Beth Miller; Wai Sze Chan; Ashley F Curtis; Jeff Boissoneault; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  Sleep Med       Date:  2018-09-05       Impact factor: 3.492

Review 6.  Fighting insomnia and battling lethargy: the yin and yang of palliative care.

Authors:  Mellar P Davis; Harold Goforth
Journal:  Curr Oncol Rep       Date:  2014-04       Impact factor: 5.075

7.  Effectiveness and gastrointestinal tolerability during conversion and titration with once-daily OROS® hydromorphone extended release in opioid-tolerant patients with chronic low back pain.

Authors:  Martin E Hale; Srinivas R Nalamachu; Arif Khan; Michael Kutch
Journal:  J Pain Res       Date:  2013-05-01       Impact factor: 3.133

8.  Opioid use, pain intensity, age, and sleep architecture in patients with fibromyalgia and insomnia.

Authors:  Ashley F Curtis; Mary Beth Miller; Himangshu Rathinakumar; Michael Robinson; Roland Staud; Richard B Berry; Christina S McCrae
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  Daily associations between sleep and opioid use among adults with comorbid symptoms of insomnia and fibromyalgia.

Authors:  Mary Beth Miller; Ashley F Curtis; Wai Sze Chan; Chelsea B Deroche; Christina S McCrae
Journal:  J Clin Sleep Med       Date:  2021-04-01       Impact factor: 4.324

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.